BFM 89.9
The Business Station
Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)
2 mins·15:45, 28 Nov 2022
2 mins
·
15:45, 28 Nov 2022
·
Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)
Recommended
Guest: Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center
Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.
Share:
Recommended
May 9
·
45 minsHow Obesity Makes Pregnancy Dangerous
May 9
·
23 minsSymphonic Image
May 9
·
20 minsThe Nutcracker
Recent episodes
0
Latest stories
Podcasts · May 9 · 8:00AM
How Obesity Makes Pregnancy Dangerous
45 mins
Podcasts · May 9 · 45 mins
How Obesity Makes Pregnancy Dangerous
Podcasts · May 9 · 7:30AM
Symphonic Image
23 mins
Podcasts · May 9 · 23 mins
Symphonic Image
Podcasts · May 9 · 7:00AM
The Nutcracker
20 mins
Podcasts · May 9 · 20 mins
The Nutcracker